High cut-off membrane for in- vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis

dc.contributor.authorCucchiari, David
dc.contributor.authorReverter, Enric
dc.contributor.authorBlasco, Miquel
dc.contributor.authorMolina Andújar, Alícia
dc.contributor.authorCarpio, Adriá
dc.contributor.authorSanz, Miquel
dc.contributor.authorEscorsell i Mañosa, M. Àngels
dc.contributor.authorFernández, Javier
dc.contributor.authorPoch López de Briñas, Esteban
dc.date.accessioned2019-05-13T11:29:09Z
dc.date.available2019-05-13T11:29:09Z
dc.date.issued2018-10-04
dc.date.updated2019-05-13T11:29:09Z
dc.description.abstractBackground: The possibility of clearing Cell-free Plasma Hemoglobin (CPH) from human plasma may appear attractive, especially when considering the noxious effects that CPH has on the immune function and the renal damage caused by its filtration. The existence of the so-called High Cut-Off (HCO) filters, possessing pores as big as 60 kDa, could potentially allow the clearance of the αβ dimers (31.3 kDa), the form in which the α2β2 hemoglobin tetramers (62.6 kDa) physiologically dissociate in plasma. We present herein the first reported case in which such an attempt was made. Case presentation: The patient was a 51-year-old man with hemolytic crisis due to glucose-6-phosphate dehydrogenase deficiency, further complicated by pigment-induced nephropathy. He underwent a 48-h CVVHD session, in which a HCO filter was used. The Sieving Coefficient (SC) for CPH was initially 0.08 and decreased to 0.02 after 24 h. This unexpected low SC was due to the initial high concentration of CPH (4.24 g/L). At such concentrations, the α2β2 tetramer poorly dissociates into the αβ dimer; but increases exponentially at concentrations lower than 1 g/L. Conclusions: Clearance of CPH through a HCO filter is technically feasible but its performance markedly relies on the initial concentration of CPH. Critically ill patients with smoldering hemolysis, as it happens during septic shock or ECMO treatment, may benefit the most from the use of this membrane in order to clear CPH.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec682476
dc.identifier.issn1471-2377
dc.identifier.pmid30286730
dc.identifier.urihttps://hdl.handle.net/2445/133073
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s12882-018-1051-x
dc.relation.ispartofBMC Neurology, 2018, vol. 19, p. 250
dc.relation.urihttps://doi.org/10.1186/s12882-018-1051-x
dc.rightscc-by (c) Cucchiari, David et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationHemoglobina
dc.subject.classificationMalalties del ronyó
dc.subject.classificationSepticèmia
dc.subject.otherHemoglobin
dc.subject.otherKidney diseases
dc.subject.otherSepticemia
dc.titleHigh cut-off membrane for in- vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
682476.pdf
Mida:
739.84 KB
Format:
Adobe Portable Document Format